BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17662987)

  • 21. Arsenic trioxide eluting stent reduces neointima formation in a rabbit iliac artery injury model.
    Yang W; Ge J; Liu H; Zhao K; Liu X; Qu X; Li W; Huang Y; Sun A; Zou Y
    Cardiovasc Res; 2006 Dec; 72(3):483-93. PubMed ID: 17020754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
    Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin II-induced hypertension: contribution of Ras GTPase/Mitogen-activated protein kinase and cytochrome P450 metabolites.
    Muthalif MM; Karzoun NA; Gaber L; Khandekar Z; Benter IF; Saeed AE; Parmentier JH; Estes A; Malik KU
    Hypertension; 2000 Oct; 36(4):604-9. PubMed ID: 11040243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small GTP binding protein Ras contributes to norepinephrine-induced mitogenesis of vascular smooth muscle cells.
    Muthalif MM; Uddin MR; Fatima S; Parmentier JH; Khandekar Z; Malik KU
    Prostaglandins Other Lipid Mediat; 2001 May; 65(1):33-43. PubMed ID: 11352225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Short-term local delivery of an inhibitor of Ras farnesyltransferase prevents neointima formation in vivo after porcine coronary balloon angioplasty.
    Work LM; McPhaden AR; Pyne NJ; Pyne S; Wadsworth RM; Wainwright CL
    Circulation; 2001 Sep; 104(13):1538-43. PubMed ID: 11571249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of curcumin for preventing restenosis in a hypercholesterolemic rabbit iliac artery stent model.
    Jang HS; Nam HY; Kim JM; Hahm DH; Nam SH; Kim KL; Joo JR; Suh W; Park JS; Kim DK; Gwon HC
    Catheter Cardiovasc Interv; 2009 Nov; 74(6):881-8. PubMed ID: 19496118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesis.
    Huang SL; Ding B; Li J; Yi FX; Liu WL; Yu QS; Guo ZG
    Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):613-7. PubMed ID: 10678124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
    Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
    Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The inhibitory mechanisms of amlodipine in human vascular smooth muscle cell proliferation.
    Zhang YZ; Gao PJ; Wang XY; Stepien O; Marche P; Zhang ZL; Zhu DL
    Hypertens Res; 2000 Jul; 23(4):403-6. PubMed ID: 10912781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cannabinoid CB1 receptor inhibition decreases vascular smooth muscle migration and proliferation.
    Rajesh M; Mukhopadhyay P; Haskó G; Pacher P
    Biochem Biophys Res Commun; 2008 Dec; 377(4):1248-52. PubMed ID: 18996082
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stent-induced restenosis in the swine coronary artery is inhibited by a platelet-derived growth factor receptor tyrosine kinase inhibitor, TKI963.
    Bilder G; Amin D; Morgan L; McVey M; Needle S; Galczenski H; Leadley R; He W; Myers M; Spada A; Luo Y; Natajaran C; Perrone M
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):817-29. PubMed ID: 12775958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RhoA inhibitor-eluting stent attenuates restenosis by inhibiting YAP signaling.
    Huang C; Zhou M; Zheng X
    J Vasc Surg; 2019 May; 69(5):1581-1589.e1. PubMed ID: 31010523
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
    Voisard R; Viola S; Kaspar V; Weber CM; von Müller L; Baur R; Gastrock-Balitsch I; Hombach V
    BMC Cardiovasc Disord; 2005 May; 5(1):9. PubMed ID: 15890069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapamycin derivative, biolimus, preferentially activates autophagy in vascular smooth muscle cells.
    Kim Y; Park JK; Seo JH; Ryu HS; Lim KS; Jeong MH; Kang DH; Kang SW
    Sci Rep; 2018 Nov; 8(1):16551. PubMed ID: 30410117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-trans and 9-cis retinoid acids inhibit proliferation, migration, and synthesis of extracellular matrix of human vascular smooth muscle cells by inducing differentiation in vitro.
    Johst U; Betsch A; Wiskirchen J; Schöber W; Vonthein R; Rinkert N; Kehlbach R; Claussen CD; Duda SH
    J Cardiovasc Pharmacol; 2003 Apr; 41(4):526-35. PubMed ID: 12658053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular responses of vascular smooth muscle cells and phagocytes to curcumin-eluting bioresorbable stent materials.
    Nguyen KT; Shaikh N; Shukla KP; Su SH; Eberhart RC; Tang L
    Biomaterials; 2004 Oct; 25(23):5333-46. PubMed ID: 15130718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of neointimal formation using miRNA-126-containing nanoparticle-conjugated stents in a rabbit model.
    Izuhara M; Kuwabara Y; Saito N; Yamamoto E; Hakuno D; Nakashima Y; Horie T; Baba O; Nishiga M; Nakao T; Nishino T; Nakazeki F; Ide Y; Kimura M; Kimura T; Ono K
    PLoS One; 2017; 12(3):e0172798. PubMed ID: 28253326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A potential strategy for in-stent restenosis: Inhibition of migration and proliferation of vascular smooth muscle cells by Cu ion.
    Zhang Y; Wang X; Ma Z; Bai B; Liu J; Yang L; Qin G; Zhang E
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111090. PubMed ID: 32600694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flufenamic acid: growth modulating effects on human aortic smooth muscle cells in vitro.
    Schöber W; Wiskirchen J; Kehlbach R; Gebert R; Rodegerdts E; Betsch A; Johst U; Claussen CD; Duda SH
    J Vasc Interv Radiol; 2002 Jan; 13(1):89-96. PubMed ID: 11788700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.